Business Wire

UPFIELD

Share
Upfield Launches World's First Plastic-free, Recyclable Tub for Its Plant Butters and Spreads

Upfield, global leader in plant-based foods, today announces the world's first plastic-free, recyclable tub for its plant butters and spreads.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240108563070/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Upfield launches world's first plastic-free, recyclable tub for its plant butters and spreads (Photo: Business Wire)

Following four years of innovation, in collaboration with Footprint, MCC and Pagès Group, this introduction marks the beginning of Upfield's transition to a paper solution across its portfolio, delivering on the company's ambition to reduce plastic content by 80% by 2030.

Initially launched in Austria with Flora Plant towards the end of 2023, Upfield expects further scaling of its paper solution, aiming to replace up to two billion plastic tubs by 2030, avoiding more than 25,000 tons of plastic waste per year.

The pioneering paper tubs were developed with Upfield’s leading Research & Development team utilising Footprint's material sciences technology. They are made from compressed wet paper fibres and are waterproof, oil-proof, and recyclable in local paper waste streams. The tub has received Conventional Plastic Free Certification and uses paper from a PEFC-certified supplier. Upfield expects the packaging to achieve home compostability certification by 2025.

David Haines, Group CEO for Upfield, commented, "As a global leader in plant-based foods, we take our responsibility to make a positive impact on the world seriously. Globally, 40% of all plastic produced is for packaging that is used once and then discarded, it is clear that the issue of plastic waste is one of the most critical facing our environment. When we established Upfield, innovating our way out of plastic tubs was our moon-shot and I am very proud of all Upfielders that continue to work towards this goal. Consumers today demand products that benefit both people and the planet. Our plant butters and spreads do exactly that. We're excited about the potential to launch this across our most iconic brands in some of our most important markets."

Unlike many paper packaging solutions, Upfield's paper tubs do not have a plastic liner so they can be recycled along with other paper and cardboard household waste, as verified by a leading European recycling company.

Karina Cerdeira, Head of Packaging for Upfield, said, "We are proud to have created, with Footprint, an innovative paper-based tub that is durable, oil-resistant and appealing and which many thought would be impossible with paper. But after years of dedicated focus from joint Upfield and Footprint R&D teams and dozens of prototypes, we made the impossible, possible. This new paper tub marks a true milestone for sustainable packaging that significantly minimises reliance on plastic. We will continue pushing boundaries through further innovation to adapt for compostability, develop new sizes and formats, and refine towards the optimal solution. We hope what we've achieved inspires other businesses to keep pursuing positive change."

Yoke Chung, Co-founder and Chief Technology & Innovation Officer for Footprint, added, "Footprint's commitment to a more sustainable planet is showcased through our partnership with Upfield. The introduction of a ground-breaking solution, in collaboration with Upfield establishes a pioneering industry standard. This marks the introduction of the first oil-resistant paper tub for plant-based spreads. We are proud to collaborate with Upfield on this transformative endeavour, as it resonates with our shared objective of assisting customers in realizing their sustainability goals. This collaborative effort underscores the transformative influence of innovation in fostering positive environmental change to shape a brighter future for everyone."

To stay up to date on the journey, follow @UpfieldGlobal on social or visit Upfield.com.

About Upfield

Upfield is a global leader in plant-based food, operating in four categories – butters and spreads, creams, liquids and cheeses. Over the last four years, Upfield has been on a journey to separate, stabilise, transform, and turn around our platform which today is unique in the plant-based space – combining scale of historical reach and scale of future growth ambition. We are built on the foundation of our power brands, which achieve high Brand Power Index versus wider consumer goods brands in all our key markets. Our brands are built upon our heritage of 150 years of knowledge of plant-based foods, deep R&D expertise, with 15 manufacturing sites across five continents and an end-to-end supply chain ensuring best service and delivery for our customers and consumers. Upfield's processes, products and people combine to create a business where our portfolio and purpose are completely aligned. www.upfield.com

About Footprint

Footprint is a global materials science and technology company with a clear vision to create a healthier planet and healthier people. Our mission is to provide solutions to eliminate single-use plastics in our food chain. Footprint's engineers use plant-based fiber technology to design, develop, and manufacture bio-based products. Footprint is rapidly expanding into new categories with customized and patented solutions for customers. While working with leading global consumer brands, Footprint's products have already led to a worldwide reduction of millions of pounds of plastic waste from entering the environment.

Footprint was founded in 2014 and employs approximately 2,000 people with operations in the U.S., Mexico, Europe, and Asia. Footprint was named to Fast Company's “Brands that Matter” list in 2022, CNBC’s “Disruptor 50” list in 2021, and Fortune’s “Change the World” list in 2020.

For more information on Footprint’s sustainable solutions, visit www.footprintus.com.

MCC Labels provides the label for the paper tub and Pagès the equipment (robot system) to apply the label.

About MCC Verstraete

MCC Verstraete has over 30 years of experience in offset-printing labels for injection molding, blow molding and thermoforming. In-depth understanding of materials, innovation and sustainability have made MCC Verstraete a world leader, producing over 60 million in mold labels every single day for numerous segments within the packaging industry. The drive for innovation recently led to 2 new product categories: next to polypropylene in mold labels, MCC Verstraete offers Molded Fiber Labeling™ and PP heat-seal die-cut lidding. MCC Verstraete has production sites in Belgium, Australia and the US. Together with MCC Korsini (Turkey) and Karydakis IML SA (Greece), MCC Verstraete forms the IML Business Unit within Multi-Color Corporation.

Visit iml.mcclabel.com/en for more information.

About Pagès Group

Pagès Group is a worldwide company with more than 40 years of expertise in decoration solutions and downstream automation for the packaging industry. The group has subsidiaries in France, in the Netherlands, the USA, Canada and China. As of today, more than 3000 automation systems have been installed in more than 45 countries. Among others, we developed Molded Fiber Labeling (MFL™), a world premiere decoration technology to decorate fiber molded containers for a sustainable and stunning packaging. To learn more about Pagès Group automation solutions, please visit www.pagesgroup.net or follow us on LinkedIn.

About EMSUR

EMSUR is the business unit of Grupo Lantero that provides flexible packaging solutions mainly for the food and beverage sector, home and personal care products, with lamination and printing in both rotogravure and flexography.

It currently has production sites in Europe and America, which allows to develop its activity in more than 80 countries across America, Europe, Africa and Asia. Emsur produces almost 600 million square metres of sleeves, lids, banners, labels, die-cuts, pouches and other flexible products per year.

Innovation, developed through the Innotech team and facilities, is one of their key pillars. Visit www.emsur.com for more information.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240108563070/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Welcomes Increased Equity Investment From L’Oréal8.12.2025 07:05:00 CET | Press release

L’Oréal to acquire an additional 10% stake in Galderma recognizing its scientific leadership in dermatology and long-term growth potential Ad hoc announcement pursuant to Art. 53 LR Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that L’Oréal Groupe intends to increase its equity investment in the company, acquiring an additional 10% stake from Sunshine SwissCo GmbH (a consortium led by EQT, Abu Dhabi Investment Authority (ADIA), and Auba Investment Pte. Ltd., acting as sellers). Following the transaction, which is subject to customary approvals, L’Oréal’s total shareholding in Galderma will rise to 20%, building on its initial investment made in August 2024. The transaction is expected to close in Q1 2026. In connection with this increased investment, Galderma will consider nominating two non-independent board candidates from L’Oréal, replacing the board members representing the consortium led by EQT, at the 2026 Annual General Meeting. Additio

Ant International Wins Champion of NeurIPS Competition of Fairness in AI Face Detection8.12.2025 04:37:00 CET | Press release

The Challenge: Deepfakes undermine both the accuracy and fairness of AI face detection due to variations in human features.The Technology: Ant International’s AI model uses a novel ‘Mixture of Experts’-based Adversarial Debiasing approach to achieve superior fairness and accuracy across diverse demographics.The Impact: This advancement strengthens payment security, offering robust protection against deepfake fraud and enhancing eKYC compliance globally. Ant International, a leading global digital payment, digitisation, and financial technology provider, has won first place at the NeurIPS Competition of Fairness in AI Face Detection. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207210856/en/ Ant International’s solution takes top spot at the NeurIPS Competition of Fairness in AI Face Detection, emerging first among over 2,100 submissions from 162 teams globally. AI Fairness enhances Financial Security Studies by the Nati

Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 00:00:00 CET | Press release

Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLLSonrotoclax in combination with BRUKINSA demonstrated rapid MRD negativity in treatment-naive CLL, regardless of high-risk features BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemi

Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse

Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release

AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye